MUSC-Hollings Cancer Center — Charleston, South Carolina

MUSC-Hollings Cancer Center is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

MUSC-Hollings Cancer Center has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Graft-versus-host Disease, Acute-graft-versus-host Disease.

Sponsors: Pfizer, Jazz Pharmaceuticals, Janssen Research & Development, LLC.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MUSC-Hollings Cancer Center?

MUSC-Hollings Cancer Center has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MUSC-Hollings Cancer Center conducted?

MUSC-Hollings Cancer Center has 3 clinical trials on record, with 1 currently active. Their work covers Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Graft-versus-host Disease, Acute-graft-versus-host Disease.

Is MUSC-Hollings Cancer Center accredited by Crixeo Health?

MUSC-Hollings Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MUSC-Hollings Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.